Bracco

Bracco, a pharmaceutical preparation manufacturer headquartered in Italy, reported approximately 98.03 million kg CO2e in Scope 1 and Scope 2 emissions for 2024. This figure comprises approximately 64.21 million kg CO2e from Scope 1 emissions and approximately 33.81 million kg CO2e from Scope 2 (market-based) emissions. For 2023, the company's Scope 1 and 2 emissions totalled approximately 98.19 million kg CO2e.

In 2022, Bracco's combined Scope 1 and 2 emissions were approximately 86.67 million kg CO2e. The previous year, 2021, saw approximately 81.34 million kg CO2e in Scope 1 and 2 emissions. For 2020, the company reported approximately 121.40 million kg CO2e for Scope 1 and 2 emissions, with approximately 71.95 million kg CO2e from Scope 1 and approximately 49.45 million kg CO2e from Scope 2 (market-based).

Bracco's 2019 emissions data indicates approximately 93.91 million kg CO2e for Scope 1 and 2 emissions, broken down into approximately 50.44 million kg CO2e for Scope 1 and approximately 43.47 million kg CO2e for Scope 2 (market-based). In 2018, Scope 1 and 2 emissions amounted to approximately 90.94 million kg CO2e, with approximately 49.47 million kg CO2e from Scope 1 and approximately 41.48 million kg CO2e from Scope 2 (market-based).

Currently, Bracco does not disclose Scope 3 emissions data, with "purchased goods and services" noted as a missing data point. The company has not disclosed specific reduction targets or commitments, such as through the Science Based Targets initiative (SBTi) or the Climate Pledge. Bracco's climate commitments and sustainability efforts would therefore be analysed through their general corporate sustainability reporting and industry best practices for pharmaceutical preparation manufacturing.